Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Delayed Toronto S.E.
Other stock markets
 02:15:06 2024-06-14 pm EDT 		5-day change 1st Jan Change
3.65 CAD 0.00% Intraday chart for Eupraxia Pharmaceuticals Inc. -2.14% -32.03%
Jun. 05 Eupraxia Pharmaceuticals Inc. Brief: Says To Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024 MT
May. 23 Eupraxia Pharmaceuticals Expanding RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
EUPRAXIA PHARMACEUTICALS INC.
Other Biotechnology & Medical Research
0.00%-2.14%-32.03%-51.33% - 94.55M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Charts Eupraxia Pharmaceuticals Inc.
  5. Comparison Chart